|
Hokkaido University Collection of Scholarly and Academic Papers >
Showing results 1 to 16 of 16
Type | Author(s) | Title | Other Titles | Citation | Citation(alt) | Issue Date | article | Nomoto, Hiroshi; Takahashi, Akihiro; Nakamura, Akinobu; Kurihara, Hiroyoshi; Takeuchi, Jun; Nagai, So; Taneda, Shinji; Miya, Aika; Kameda, Hiraku; Cho, Kyu Yong; Miyoshi, Hideaki; Atsumi, Tatsuya | Add-on imeglimin versus metformin dose escalation regarding glycemic control in patients with type 2 diabetes treated with a dipeptidyl peptidase-4 inhibitor plus low-dose metformin : study protocol for a multicenter, prospective, randomized, open-label, parallel-group comparison study (MEGMI study) | - | Bmj open diabetes research and care | - | Nov-2022 |
article | Yamauchi, Yuki; Nakamura, Akinobu; Yokota, Takashi; Takahashi, Kiyohiko; Kawata, Shinichiro; Tsuchida, Kazuhisa; Omori, Kazuno; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Anzai, Toshihisa; Tanaka, Shinya; Terauchi, Yasuo; Miyoshi, Hideaki; Atsumi, Tatsuya | Luseogliflozin preserves the pancreatic beta-cell mass and function in db/db mice by improving mitochondrial function | - | Scientific reports | - | 13-Jun-2022 |
article | Nomoto, Hiroshi; Furusawa, Sho; Nakamura, Akinobu; Takeuchi, Jun; Nagai, So; Yokoyama, Hiroki; Sakuma, Ichiro; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; Miya, Aika; Kameda, Hiraku; Cho, Kyu Yong; Atsumi, Tatsuya; Miyoshi, Hideaki | Effects of switching from a dipeptidyl peptidase-4 inhibitor to oral semaglutide on glucose metabolism in patients with type 2 diabetes : protocol for a multicentre, prospective, randomised, open-label, parallel-group comparison study (the SWITCH-SEMA 2 st | - | BMJ Open | - | May-2022 |
article | Oba-Yamamoto, Chiho; Takeuchi, Jun; Nakamura, Akinobu; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Y.; Atsumi, Tatsuya; Miyoshi, Hideaki | Impact of low-starch high-fiber pasta on postprandial blood glucose | - | Nutrition, Metabolism and Cardiovascular Diseases | - | Feb-2022 |
article | Kamoshima, Hikaru; Nomoto, Hiroshi; Yamashita, Kumiko; Takahashi, Yuka; Tsuchida, Kazuhisa; Kuwabara, Saki; Miya, Aika; Cho, Kyu Yong; Kameda, Hiraku; Nakamura, Akinobu; Atsumi, Tatsuya; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; Ono, Yuri; Miyoshi, Hideaki | Do the benefits of sodium-glucose cotransporter 2 inhibitors exceed the risks in patients with type 1 diabetes? | - | Endocrine journal | - | 28-Jan-2022 |
article | Miya, Aika; Nakamura, Akinobu; Cho, Kyu Yong; Kawata, Shinichiro; Nomoto, Hiroshi; Nagai, So; Sugawara, Hajime; Taneda, Shinji; Tsuchida, Kazuhisa; Omori, Kazuno; Yokoyama, Hiroki; Takeuchi, Jun; Aoki, Shin; Kurihara, Yoshio; Atsumi, Tatsuya; Miyoshi, Hideaki | Impact of endogenous insulin secretion on the improvement of glucose variability in Japanese patients type 2 diabetes treated with canagliflozin plus teneligliptin | - | Journal of Diabetes Investigation | - | 10-Aug-2021 |
article | Cho, Kyu Yong; Nomoto, Hiroshi; Nakamura, Akinobu; Kawata, Shinichiro; Sugawara, Hajime; Takeuchi, Jun; Nagai, So; Omori, Kazuno; Tsuchida, Kazuhisa; Miya, Aika; Shigesawa, Ikumi; Tsuchida, Kenichi; Yanagiya, Shingo; Kameda, Hiraku; Yokoyama, Hiroki; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; Nishimoto, Naoki; Atsumi, Tatsuya; Miyoshi, Hideaki | Improved Time in Range and Postprandial Hyperglycemia with Canagliflozin in Combination with Teneligliptin : Secondary Analyses of the CALMER study | - | Journal of Diabetes Investigation | - | 10-Aug-2021 |
article | Cho, Kyu Yong; Nakamura, Akinobu; Omori, Kazuno; Takase, Takahiro; Miya, Aika; Yamamoto, Kohei; Nomoto, Hiroshi; Kameda, Hiraku; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, Hideaki | Favorable effect of sodium–glucose cotransporter 2 inhibitor, dapagliflozin, on non‐alcoholic fatty liver disease compared with pioglitazone | - | Journal of Diabetes Investigation | - | 8-Jul-2021 |
article | Miya, Aika; Nakamura, Akinobu; Handa, Takahisa; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Nagai, So; Miyoshi, Hideaki; Atsumi, Tatsuya | Impaired insulin secretion predicting unstable glycemic variability and time below range in type 2 diabetes patients regardless of glycated hemoglobin or diabetes treatment | - | Journal of diabetes investigation | - | May-2021 |
article | Oba‐Yamamoto, Chiho; Takeuchi, Jun; Nakamura, Akinobu; Takikawa, Ryoko; Ozaki, Ayano; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Atsumi, Tatsuya; Miyoshi, Hideaki | Combination of alcohol and glucose consumption as a risk to induce reactive hypoglycemia | - | Journal of Diabetes Investigation | - | Apr-2021 |
article | Nomoto, Hiroshi; Oba-Yamamoto, Chiho; Takahashi, Yuka; Takeuchi, Jun; Nagai, So; Yokoyama, Hiroki; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; Kameda, Hiraku; Cho, Kyu Yong; Nakamura, Akinobu; Atsumi, Tatsuya; Miyoshi, Hideaki | Effects of Switching from Liraglutide or Dulaglutide to Subcutaneous Semaglutide on Glucose Metabolism and Treatment Satisfaction in Patients with Type 2 Diabetes : Protocol for a Multicenter, Prospective, Randomized, Open-Label, Blinded-Endpoint, Parallel-Group Comparison Study (The SWITCH-SEMA 1 Study) | - | Diabetes Therapy | - | Mar-2021 |
article | Chiba, Koki; Nomoto, Hiroshi; Nakamura, Akinobu; Cho, Kyu Yong; Yamashita, Kumiko; Shibayama, Yui; Miya, Aika; Kameda, Hiraku; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, Hideaki | Sodium–glucose cotransporter 2 inhibitors reduce day-to-day glucose variability in patients with type 1 diabetes | - | Journal of Diabetes Investigation | - | Feb-2021 |
article | Yuno, Akiko; Kenmotsu, Yoshiyuki; Takahashi, Yuka; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Nakamura, Akinobu; Yamashita, Yu; Nakamura, Junichi; Nakakubo, Sho; Kamada, Keisuke; Suzuki, Masaru; Sugino, Hirokazu; Inoshita, Naoko; Konno, Satoshi; Miyoshi, Hideaki; Atsumi, Tatsuya; Sawamura, Yutaka; Shimatsu, Akira | Successful management of a patient with active Cushing’s disease complicated with coronavirus disease 2019 (COVID-19) pneumonia | - | Endocrine Journal | - | Feb-2021 |
article | Chiba, Koki; Nomoto, Hiroshi; Nakamura, Akinobu; Cho, Kyu Yong; Yamashita, Kumiko; Shibayama, Yui; Miya, Aika; Kameda, Hiraku; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, Hideaki | Sodium-glucose cotransporter 2 inhibitors reduce day-to-day glucose variability in patients with type 1 diabetes | - | Journal of diabetes investigation | - | Feb-2021 |
article | Baba, Natsuki; Kameda, Hiraku; Nakamura, Akinobu; Yong Cho, Kyu; Nomoto, Hiroshi; Mitsuhashi, Tomoko; Miyoshi, Hideaki; Atsumi, Tatsuya | Silent pituitary adenoma and metabolic disorders : obesity, abnormal glucose tolerance, hypertension and dyslipidemia | - | Endocrine Journal | - | 2021 |
article (author version) | Kato, Masaru; Hattori, Toshiyuki; Shimizu, Tomohiro; Ninagawa, Keita; Izumihara, Rimi; Nomoto, Hiroshi; Tanimura, Kazuhide; Atsumi, Tatsuya | Intrafamilial phenotypic distinction of hypophosphatasia with identical tissue nonspecific alkaline phosphatase gene mutation : a family report | - | Journal of Bone and Mineral Metabolism | - | Nov-2020 |
Showing results 1 to 16 of 16
|